These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

932 related articles for article (PubMed ID: 29344756)

  • 1. The Current State of Left Main Percutaneous Coronary Intervention.
    Avula HR; Rassi AN
    Curr Atheroscler Rep; 2018 Jan; 20(1):3. PubMed ID: 29344756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.
    Giacoppo D; Colleran R; Cassese S; Frangieh AH; Wiebe J; Joner M; Schunkert H; Kastrati A; Byrne RA
    JAMA Cardiol; 2017 Oct; 2(10):1079-1088. PubMed ID: 28903139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
    Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of SYNTAX Score on 10-Year Outcomes After Revascularization for Left Main Coronary Artery Disease.
    Yoon YH; Ahn JM; Kang DY; Park H; Cho SC; Lee PH; Lee SW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2020 Feb; 13(3):361-371. PubMed ID: 32029254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 7. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease.
    Garg A; Rao SV; Agrawal S; Theodoropoulos K; Mennuni M; Sharma A; Garg L; Ferrante G; Meelu OA; Sargsyan D; Reimers B; Cohen M; Kostis JB; Stefanini GG
    Am J Cardiol; 2017 Jun; 119(12):1942-1948. PubMed ID: 28433215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of coronary artery bypass grafting versus stent-PCI for unprotected left main disease: a meta-analysis.
    De Rosa S; Polimeni A; Sabatino J; Indolfi C
    BMC Cardiovasc Disord; 2017 Sep; 17(1):240. PubMed ID: 28877676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era--an aggregate data meta-analysis of 11,148 patients.
    Alam M; Huang HD; Shahzad SA; Kar B; Virani SS; Rogers PA; Paniagua D; Bozkurt B; Palacios I; Kleiman NS; Jneid H
    Circ J; 2013; 77(2):372-82. PubMed ID: 23123552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting.
    Athappan G; Patvardhan E; Tuzcu ME; Ellis S; Whitlow P; Kapadia SR
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1219-30. PubMed ID: 24355112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 10-Year Outcomes of Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease.
    Park DW; Ahn JM; Yun SC; Yoon YH; Kang DY; Lee PH; Lee SW; Park SW; Seung KB; Gwon HC; Jeong MH; Jang Y; Kim HS; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Park SJ
    J Am Coll Cardiol; 2018 Dec; 72(23 Pt A):2813-2822. PubMed ID: 30261236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-Eluting Stents Versus Coronary Artery Bypass Grafts for Left Main Coronary Disease: A Meta-Analysis and Review of Randomised Controlled Trials.
    Moore P; Burrage M; Garrahy P; Lim R; McCann A; Camuglia A
    Heart Lung Circ; 2018 Dec; 27(12):1437-1445. PubMed ID: 29102437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of randomized controlled trials on the treatment of unprotected left main coronary artery disease: one-year outcomes with coronary artery bypass grafting versus percutaneous coronary artery intervention with drug-eluting stent.
    Kajimoto K; Miyauchi K; Yamamoto T; Daida H; Amano A
    J Card Surg; 2012 Mar; 27(2):152-7. PubMed ID: 22364383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.
    Sabatine MS; Bergmark BA; Murphy SA; O'Gara PT; Smith PK; Serruys PW; Kappetein AP; Park SJ; Park DW; Christiansen EH; Holm NR; Nielsen PH; Stone GW; Sabik JF; Braunwald E
    Lancet; 2021 Dec; 398(10318):2247-2257. PubMed ID: 34793745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of three randomized controlled trials comparing coronary artery bypass grafting with percutaneous coronary intervention using drug-eluting stenting in patients with diabetes.
    Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1002-7. PubMed ID: 25185569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.
    Stone GW; Sabik JF; Serruys PW; Simonton CA; Généreux P; Puskas J; Kandzari DE; Morice MC; Lembo N; Brown WM; Taggart DP; Banning A; Merkely B; Horkay F; Boonstra PW; van Boven AJ; Ungi I; Bogáts G; Mansour S; Noiseux N; Sabaté M; Pomar J; Hickey M; Gershlick A; Buszman P; Bochenek A; Schampaert E; Pagé P; Dressler O; Kosmidou I; Mehran R; Pocock SJ; Kappetein AP;
    N Engl J Med; 2016 Dec; 375(23):2223-2235. PubMed ID: 27797291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term outcomes of new generation drug eluting stents versus coronary artery bypass grafting for multivessel and/or left main coronary artery disease. A Bayesian network meta-analysis of randomized controlled trials.
    Mina GS; Watti H; Soliman D; Shewale A; Atkins J; Reddy P; Dominic P
    Cardiovasc Revasc Med; 2018 Sep; 19(6):671-678. PubMed ID: 29396239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.